Phospho-p38 MAPK (Thr180/Tyr182) (28B10) Mouse Monoclonal Antibody and 3 more items

Cell Signaling Technology Inc. was awarded contract A207_PO-0443374-V3 by the University of Virginia on August 8, 2026, with a cumulative contract value of $592. The contract is for the supply of monoclonal antibodies, which are laboratory reagents used in research and diagnostic applications. The specific products procured include four distinct antibody variants: Phospho-p38 Mitogen-Activated Protein Kinase (Thr180/Tyr182) (28B10) Mouse Monoclonal Antibody (177 units), p38 Mitogen-Activated Protein Kinase (D13E1) Rabbit Monoclonal Antibody (144 units), Ki-67 (D3B5) Rabbit Monoclonal Antibody (136 units), and Akt (pan) (40D4) Mouse Monoclonal Antibody (133 units), totaling 590 units across all line items.

The contract represents a procurement of research-grade biological reagents for use by the University of Virginia, a state institution in Virginia. All items are designated for delivery to the contracting organization's buyer. The relatively modest cumulative contract value of $592 reflects unit pricing of $1 per antibody vial, indicating this was a targeted, small-volume procurement of specialized laboratory materials for ongoing research activities at the institution.